purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Veterinary Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Veterinary Pharmaceuticals
1.2 Veterinary Pharmaceuticals Segment by Type
1.2.1 Global Veterinary Pharmaceuticals Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Veterinary Biological Drugs
1.2.3 Veterinary Preparations
1.2.4 Others
1.3 Veterinary Pharmaceuticals Segment by Application
1.3.1 Global Veterinary Pharmaceuticals Sales Comparison by Application: (2022-2028)
1.3.2 Poultry
1.3.3 Pets
1.3.4 Other
1.4 Global Veterinary Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Veterinary Pharmaceuticals Revenue 2017-2028
1.4.2 Global Veterinary Pharmaceuticals Sales 2017-2028
1.4.3 Veterinary Pharmaceuticals Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Pharmaceuticals Market Competition by Manufacturers
2.1 Global Veterinary Pharmaceuticals Sales Market Share by Manufacturers (2017-2022)
2.2 Global Veterinary Pharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Veterinary Pharmaceuticals Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Veterinary Pharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Veterinary Pharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Pharmaceuticals Players Market Share by Revenue
2.5.3 Global Veterinary Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Pharmaceuticals Retrospective Market Scenario by Region
3.1 Global Veterinary Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Veterinary Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.3.1 North America Veterinary Pharmaceuticals Sales by Country
3.3.2 North America Veterinary Pharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Veterinary Pharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Veterinary Pharmaceuticals Sales by Country
3.4.2 Europe Veterinary Pharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Pharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Pharmaceuticals Sales by Region
3.5.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Veterinary Pharmaceuticals Sales by Country
3.6.2 Latin America Veterinary Pharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Veterinary Pharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Country
3.7.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Pharmaceuticals Historic Market Analysis by Type
4.1 Global Veterinary Pharmaceuticals Sales Market Share by Type (2017-2022)
4.2 Global Veterinary Pharmaceuticals Revenue Market Share by Type (2017-2022)
4.3 Global Veterinary Pharmaceuticals Price by Type (2017-2022)
5 Global Veterinary Pharmaceuticals Historic Market Analysis by Application
5.1 Global Veterinary Pharmaceuticals Sales Market Share by Application (2017-2022)
5.2 Global Veterinary Pharmaceuticals Revenue Market Share by Application (2017-2022)
5.3 Global Veterinary Pharmaceuticals Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Zoetis(Pfizer)
6.1.1 Zoetis(Pfizer) Corporation Information
6.1.2 Zoetis(Pfizer) Description and Business Overview
6.1.3 Zoetis(Pfizer) Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Zoetis(Pfizer) Veterinary Pharmaceuticals Product Portfolio
6.1.5 Zoetis(Pfizer) Recent Developments/Updates
6.2 MERIAL
6.2.1 MERIAL Corporation Information
6.2.2 MERIAL Description and Business Overview
6.2.3 MERIAL Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.2.4 MERIAL Veterinary Pharmaceuticals Product Portfolio
6.2.5 MERIAL Recent Developments/Updates
6.3 Merial
6.3.1 Merial Corporation Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merial Veterinary Pharmaceuticals Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Lilly
6.4.1 Lilly Corporation Information
6.4.2 Lilly Description and Business Overview
6.4.3 Lilly Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lilly Veterinary Pharmaceuticals Product Portfolio
6.4.5 Lilly Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bayer Veterinary Pharmaceuticals Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Boehringer
6.6.1 Boehringer Corporation Information
6.6.2 Boehringer Description and Business Overview
6.6.3 Boehringer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Boehringer Veterinary Pharmaceuticals Product Portfolio
6.6.5 Boehringer Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Veterinary Pharmaceuticals Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Corporation Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Virbac Veterinary Pharmaceuticals Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Ceva
6.9.1 Ceva Corporation Information
6.9.2 Ceva Description and Business Overview
6.9.3 Ceva Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Ceva Veterinary Pharmaceuticals Product Portfolio
6.9.5 Ceva Recent Developments/Updates
6.10 Vetoquinol
6.10.1 Vetoquinol Corporation Information
6.10.2 Vetoquinol Description and Business Overview
6.10.3 Vetoquinol Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Vetoquinol Veterinary Pharmaceuticals Product Portfolio
6.10.5 Vetoquinol Recent Developments/Updates
6.11 CAHIC
6.11.1 CAHIC Corporation Information
6.11.2 CAHIC Veterinary Pharmaceuticals Description and Business Overview
6.11.3 CAHIC Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.11.4 CAHIC Veterinary Pharmaceuticals Product Portfolio
6.11.5 CAHIC Recent Developments/Updates
6.12 Ringpu
6.12.1 Ringpu Corporation Information
6.12.2 Ringpu Veterinary Pharmaceuticals Description and Business Overview
6.12.3 Ringpu Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ringpu Veterinary Pharmaceuticals Product Portfolio
6.12.5 Ringpu Recent Developments/Updates
6.13 Dahuanong
6.13.1 Dahuanong Corporation Information
6.13.2 Dahuanong Veterinary Pharmaceuticals Description and Business Overview
6.13.3 Dahuanong Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Dahuanong Veterinary Pharmaceuticals Product Portfolio
6.13.5 Dahuanong Recent Developments/Updates
6.14 TECON
6.14.1 TECON Corporation Information
6.14.2 TECON Veterinary Pharmaceuticals Description and Business Overview
6.14.3 TECON Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.14.4 TECON Veterinary Pharmaceuticals Product Portfolio
6.14.5 TECON Recent Developments/Updates
6.15 BIOK
6.15.1 BIOK Corporation Information
6.15.2 BIOK Veterinary Pharmaceuticals Description and Business Overview
6.15.3 BIOK Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.15.4 BIOK Veterinary Pharmaceuticals Product Portfolio
6.15.5 BIOK Recent Developments/Updates
6.16 Lukang Pharma
6.16.1 Lukang Pharma Corporation Information
6.16.2 Lukang Pharma Veterinary Pharmaceuticals Description and Business Overview
6.16.3 Lukang Pharma Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Lukang Pharma Veterinary Pharmaceuticals Product Portfolio
6.16.5 Lukang Pharma Recent Developments/Updates
6.17 JINYU Group
6.17.1 JINYU Group Corporation Information
6.17.2 JINYU Group Veterinary Pharmaceuticals Description and Business Overview
6.17.3 JINYU Group Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.17.4 JINYU Group Veterinary Pharmaceuticals Product Portfolio
6.17.5 JINYU Group Recent Developments/Updates
6.18 China Animal Healthcare
6.18.1 China Animal Healthcare Corporation Information
6.18.2 China Animal Healthcare Veterinary Pharmaceuticals Description and Business Overview
6.18.3 China Animal Healthcare Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.18.4 China Animal Healthcare Veterinary Pharmaceuticals Product Portfolio
6.18.5 China Animal Healthcare Recent Developments/Updates
6.19 Jiangxi Yiling
6.19.1 Jiangxi Yiling Corporation Information
6.19.2 Jiangxi Yiling Veterinary Pharmaceuticals Description and Business Overview
6.19.3 Jiangxi Yiling Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Jiangxi Yiling Veterinary Pharmaceuticals Product Portfolio
6.19.5 Jiangxi Yiling Recent Developments/Updates
6.20 JIZHONG Pharmaceutical
6.20.1 JIZHONG Pharmaceutical Corporation Information
6.20.2 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Description and Business Overview
6.20.3 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.20.4 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Product Portfolio
6.20.5 JIZHONG Pharmaceutical Recent Developments/Updates
7 Veterinary Pharmaceuticals Manufacturing Cost Analysis
7.1 Veterinary Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Pharmaceuticals
7.4 Veterinary Pharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Pharmaceuticals Distributors List
8.3 Veterinary Pharmaceuticals Customers
9 Veterinary Pharmaceuticals Market Dynamics
9.1 Veterinary Pharmaceuticals Industry Trends
9.2 Veterinary Pharmaceuticals Market Drivers
9.3 Veterinary Pharmaceuticals Market Challenges
9.4 Veterinary Pharmaceuticals Market Restraints
10 Global Market Forecast
10.1 Veterinary Pharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Type (2023-2028)
10.2 Veterinary Pharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Application (2023-2028)
10.3 Veterinary Pharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer